The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...
FRANKLIN LAKES, N.J., July 18, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls ...
FDA has given Class I status to a Carefusion recall related to the Alaris Model 8100 infusion pump. A software failure in the pump had been identified in modules running software version 9.1.18. Last ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback